Bicara Therapeutics President, COO and interim CEO Ryan Cohlhepp disposes of common shares worth $400,049.15
BCAX•Cohlhepp reduces Bicara stake
Ryan Cohlhepp, president, COO, interim CEO, director, cut his Bicara stake to 181,641 common shares on Sep. 8, 2026.
He disposed of 17,500 shares at $3.79 via option exercise, then sold 17,500 shares at weighted-average prices of $22.77 and $23.43.
